<DOC>
	<DOCNO>NCT00724685</DOCNO>
	<brief_summary>Continuous bupivacaine administration elastomeric pump ( Pain Buster ) find effective post operative analgesia large range surgery . Ropivacaine less toxic drug , never test surgery latissimus dorsi serratus micro anastomotic flap ( investigator knowledge ) . The aim study evaluate usefulness drug device post operative analgesia , associate patient control analgesia morphine . For purpose control randomize double blind trial placebo ( saline ) perform , enrol 40 ( 20x2 ) patient 3 year , order measure total morphine consumption first 48 post operative hour evaluate analgesia side effect morphine group .</brief_summary>
	<brief_title>Interest Continuous Ropivacaine Administration Through Elastomeric Pump ( Pain Buster ) Surgery Latissimus Dorsi Serratus Micro Anastomotic Flaps</brief_title>
	<detailed_description />
	<mesh_term>Ropivacaine</mesh_term>
	<criteria>operate latissimus dorsi serratus micro anastomotic flap . 18 75 year old ASA III hospitalize Nantes CHU Burns ICU give write informed consent healthcare protection decline study know side effect morphine local anesthetic know allergy reaction use drug disease incompatible anaesthetic procedure law protection take antiepileptic antidepressant drug pregnant ( gender criterion )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Ropivacaine</keyword>
	<keyword>elastomeric pump</keyword>
	<keyword>patient control analgesia</keyword>
	<keyword>morphine consumption</keyword>
</DOC>